Anchor Therapeutics Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
Anchor Therapeutics General Information
Description
Developer of a pharmaceutical platform designed to treat cancer, inflammation, metabolism, heart disease, and pain. The company's pharmaceutical platform includes the development of Pepducin lipopeptide drug candidates and molecules that target the intracellular domains of G protein-coupled receptors (GPCRs) to allosterically modulate GPCR signaling, providing healthcare professionals with new treatment options for regenerative medicine, diabetes, inflammation, and cancer.
Contact Information
Website
www.anchortx.comCorporate Office
- One Kendall Square
- Building 200, Suite 2203
- Cambridge, MA 02139
- United States
Corporate Office
- One Kendall Square
- Building 200, Suite 2203
- Cambridge, MA 02139
- United States
Anchor Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 19-Aug-2016 | Completed | Profitable | |||
| 5. Merger/Acquisition | 20-Mar-2015 | Completed | Profitable | |||
| 4. Early Stage VC | 01-May-2012 | Completed | Profitable | |||
| 3. Early Stage VC | 23-Aug-2010 | Completed | Profitable | |||
| 2. Early Stage VC (Series B) | 20-Aug-2010 | $10M | $29M | Completed | Profitable | |
| 1. Early Stage VC (Series A) | 18-Nov-2008 | $19M | $19M | Completed | Profitable |
Anchor Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Anchor Therapeutics Comparisons
Industry
Financing
Details
Anchor Therapeutics Competitors (55)
One of Anchor Therapeutics’s 55 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| Qu Biologics | Private Equity-Backed | Burnaby, Canada | ||||
| Vera Therapeutics | Formerly VC-backed | Brisbane, CA | ||||
| Vertex Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| Sanofi Pasteur | Corporation | Paris, France |
Anchor Therapeutics Patents
Anchor Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3021861-A1 | Apj receptor compounds | Inactive | 18-Jul-2013 | ||
| US-20160159861-A1 | Apj receptor compounds | Inactive | 18-Jul-2013 | ||
| WO-2015010045-A1 | Apj receptor compounds | Inactive | 18-Jul-2013 | ||
| AU-2013208109-A1 | Apj receptor compounds | Inactive | 09-Jan-2012 | ||
| CA-2860740-A1 | Apj receptor compounds | Inactive | 09-Jan-2012 | C07K7/08 |
Anchor Therapeutics Signals
Anchor Therapeutics Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Acer Therapeutics | Corporation | Majority | ||
| HealthCare Ventures | Venture Capital | Minority | ||
| Novartis Venture Fund | Corporate Venture Capital | Minority | ||
| TVM Capital | Venture Capital | Minority |
Anchor Therapeutics FAQs
-
When was Anchor Therapeutics founded?
Anchor Therapeutics was founded in 2006.
-
Where is Anchor Therapeutics headquartered?
Anchor Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Anchor Therapeutics?
Anchor Therapeutics has 4 total employees.
-
What industry is Anchor Therapeutics in?
Anchor Therapeutics’s primary industry is Drug Discovery.
-
Is Anchor Therapeutics a private or public company?
Anchor Therapeutics is a Private company.
-
What is Anchor Therapeutics’s current revenue?
The current revenue for Anchor Therapeutics is .
-
How much funding has Anchor Therapeutics raised over time?
Anchor Therapeutics has raised $34M.
-
Who are Anchor Therapeutics’s investors?
Acer Therapeutics, HealthCare Ventures, Novartis Venture Fund, and TVM Capital have invested in Anchor Therapeutics.
-
Who are Anchor Therapeutics’s competitors?
Voyager Therapeutics, Qu Biologics, Vera Therapeutics, Vertex Pharmaceuticals, and Sanofi Pasteur are some of the 55 competitors of Anchor Therapeutics.
-
When was Anchor Therapeutics acquired?
Anchor Therapeutics was acquired on 19-Aug-2016.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process